# EDGAR Filing Document

**Accession Number:** 0001757499
**File Stem:** 0001493152-23-002715
**Filing Date:** 2023-1
**Character Count:** 2407
**Document Hash:** c6071dd862f62ef2b3275596d6cae5a4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-002715.hdr.sgml**: 20230302

**ACCESSION NUMBER**: 0001493152-23-002715

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230127

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Shuttle Pharmaceuticals Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001757499
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** ONE RESEARCH COURT
- **STREET 2:** SUITE 450
- **CITY:** ROCKVILLE
- **STATE:** MD
- **ZIP:** 20850
- **BUSINESS PHONE:** 2404034212

**MAIL ADDRESS:**
- **STREET 1:** ONE RESEARCH COURT
- **STREET 2:** SUITE 450
- **CITY:** ROCKVILLE
- **STATE:** MD
- **ZIP:** 20850

January 27, 2023

***Via EDGAR***

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3720

Attention: Daniel Crawford

---

| | |
|:---|:---|
| **Re:** | **Shuttle Pharmaceuticals Holdings, Inc.** |
|  | **Registration Statement on Form S-1 (File No. 333-269414)** |
|  | **Withdraw of Acceleration Request** |

---

Dear Mr. Crawford:

Reference is made to our letter, filed as correspondence via EDGAR on January 25, 2023, in which the registrant, Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (the "<u>Company</u>"), requested the acceleration of the effective date of the above referenced Registration Statement on Form S-1 (the "<u>Registration Statement</u>") for 5 pm Eastern Time on Friday, January 27, 2023, or as soon thereafter as reasonably practicable (the "<u>Effective Time</u>"), in accordance with Rule 460 and 461 under the Securities Act of 1933, as amended.

The Company is no longer requesting that such Registration Statement be declared effective at the Effective Time and we hereby formally withdraw our request for acceleration of the effective date until further notice from the Company.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. |
| By: | */s/ Anatoly Dritschilo* |
|  | Anatoly Dritschilo, M.D. |
|  | Chief Executive Officer |

---

cc: Megan J. Penick, Esq., <br> Michelman & Robinson, LLP